Scarica l'app Stockscreener
3.56
5.57%
-0.21
Dopo l'orario di chiusura:
3.47
-0.09
-2.53%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.77
Aprire:
$3.72
Volume 24 ore:
2.76M
Relative Volume:
0.77
Capitalizzazione di mercato:
$384.14M
Reddito:
-
Utile/perdita netta:
$-258.08M
Rapporto P/E:
-1.2945
EPS:
-2.75
Flusso di cassa netto:
$-202.32M
1 W Prestazione:
-9.64%
1M Prestazione:
+13.02%
6M Prestazione:
-55.56%
1 anno Prestazione:
-79.03%
Intervallo 1D:
$3.42
$3.85
Intervallo di 1 settimana:
$3.42
$4.03
Portata 52W:
$2.19
$18.17
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Nome
Rocket Pharmaceuticals Inc
Settore
Industria
Telefono
646-440-9100
Indirizzo
350 FIFTH AVENUE, NEW YORK, NY
Confronta RCKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.56 | 406.80M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-07-25 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-05-30 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-05-28 | Downgrade | Goldman | Neutral → Sell |
| 2025-05-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-05-28 | Downgrade | Jefferies | Buy → Hold |
| 2025-05-28 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-05-28 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-27 | Downgrade | Needham | Buy → Hold |
| 2025-05-27 | Downgrade | TD Cowen | Buy → Hold |
| 2025-03-12 | Iniziato | BMO Capital Markets | Outperform |
| 2024-12-30 | Iniziato | Wedbush | Outperform |
| 2024-12-18 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-04-02 | Iniziato | Goldman | Neutral |
| 2023-10-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-02-01 | Iniziato | Morgan Stanley | Overweight |
| 2022-11-08 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-01 | Iniziato | BTIG Research | Buy |
| 2022-07-08 | Iniziato | Raymond James | Outperform |
| 2021-10-20 | Ripresa | Cowen | Outperform |
| 2021-03-02 | Iniziato | Stifel | Buy |
| 2021-02-18 | Iniziato | Needham | Buy |
| 2020-12-16 | Iniziato | UBS | Buy |
| 2020-12-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-07-02 | Iniziato | JP Morgan | Overweight |
| 2020-06-25 | Ripresa | BofA/Merrill | Buy |
| 2020-06-01 | Ripresa | Oppenheimer | Outperform |
| 2019-11-06 | Iniziato | Chardan Capital Markets | Buy |
| 2019-09-26 | Iniziato | Piper Jaffray | Overweight |
| 2019-04-23 | Iniziato | Robert W. Baird | Outperform |
| 2019-03-15 | Iniziato | BofA/Merrill | Buy |
| 2019-02-05 | Iniziato | Oppenheimer | Outperform |
| 2018-09-13 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-10 | Iniziato | William Blair | Outperform |
Mostra tutto
Rocket Pharmaceuticals Inc Borsa (RCKT) Ultime notizie
Published on: 2025-11-03 08:59:54 - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock benefits from tech adoption2025 Pullback Review & Daily Stock Trend Reports - newser.com
Can Rocket Pharmaceuticals Inc. stock deliver strong Q4 earningsMarket Activity Recap & Verified Swing Trading Watchlists - newser.com
Is it time to cut losses on Rocket Pharmaceuticals Inc. Equity WarrantMarket Growth Summary & Weekly Breakout Watchlists - newser.com
Rocket Pharmaceuticals Inc. stock chart pattern explainedOil Prices & Long-Term Growth Stock Strategies - newser.com
Is Rocket Pharmaceuticals Inc. stock entering bullish territoryJuly 2025 Fed Impact & Real-Time Chart Pattern Alerts - newser.com
Using R and stats models for Rocket Pharmaceuticals Inc. forecasting2025 Market Outlook & Community Supported Trade Ideas - newser.com
Using data models to predict Rocket Pharmaceuticals Inc. Equity Warrant stock movement2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com
Long term hold vs stop loss in Rocket Pharmaceuticals Inc.2025 Support & Resistance & Short-Term High Return Ideas - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
How to integrate Rocket Pharmaceuticals Inc. Equity Warrant into portfolio analysis tools2025 Investor Takeaways & Smart Money Movement Tracker - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock see insider accumulationJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock good for wealth creationMarket Trend Report & Safe Capital Growth Tips - newser.com
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc. Equity Warrant2025 Volatility Report & Free Weekly Watchlist of Top Performers - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock trades pre earningsMarket Activity Recap & Verified Entry Point Signals - newser.com
What dividend safety score for Rocket Pharmaceuticals Inc. stockPortfolio Value Summary & Daily Volume Surge Signals - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock a safe haven assetWeekly Stock Recap & AI Powered Trade Plan Recommendations - newser.com
Published on: 2025-11-03 01:22:42 - newser.com
Sentiment analysis tools applied to Rocket Pharmaceuticals Inc.Trade Exit Report & Free AI Powered Buy and Sell Recommendations - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock reacts to inflationary pressures2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Is Rocket Pharmaceuticals Inc. Equity Warrant stock poised for growthJuly 2025 Patterns & Weekly Top Gainers Trade List - newser.com
Rocket Pharmaceuticals Inc. Equity Warrant recovery potential after sell offQuarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock compares to industry benchmarksWeekly Gains Report & Low Risk Entry Point Tips - newser.com
What technical models suggest about Rocket Pharmaceuticals Inc.’s comeback2025 Fundamental Recap & Weekly Momentum Stock Picks - newser.com
Applying big data sentiment scoring on Rocket Pharmaceuticals Inc.2025 Macro Impact & Technical Confirmation Alerts - newser.com
Will a bounce in Rocket Pharmaceuticals Inc. offer an exitWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
Why Rocket Pharmaceuticals Inc. stock is in analyst buy zoneJuly 2025 Pullbacks & Weekly Top Gainers Alerts - newser.com
How to use Fibonacci retracement on Rocket Pharmaceuticals Inc.Trade Risk Assessment & Daily Volume Surge Signals - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued historicallyJuly 2025 Update & Accurate Technical Buy Alerts - newser.com
Why Rocket Pharmaceuticals Inc. (9IP1) stock attracts wealthy investors2025 Technical Patterns & Precise Buy Zone Identification - newser.com
Published on: 2025-11-02 06:26:40 - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant see short term momentumWeekly Trade Recap & Daily Profit Maximizing Tips - newser.com
Rocket Pharmaceuticals Inc. recovery potential after sell off2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
Order flow analysis tools used on Rocket Pharmaceuticals Inc. Equity WarrantPortfolio Risk Summary & Reliable Entry Point Trade Alerts - newser.com
Detecting support and resistance levels for Rocket Pharmaceuticals Inc.2025 Market Sentiment & Weekly Stock Breakout Alerts - newser.com
Rocket Pharmaceuticals Inc Azioni (RCKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):